189 related articles for article (PubMed ID: 19938949)
1. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
[TBL] [Abstract][Full Text] [Related]
2. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
3. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
[TBL] [Abstract][Full Text] [Related]
4. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
5. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
6. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.
Agarwal A; Agrawal H; Tiwari S; Jain S; Agrawal GP
Int J Pharm; 2011 Dec; 421(1):189-201. PubMed ID: 21986113
[TBL] [Abstract][Full Text] [Related]
7. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
8. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
[TBL] [Abstract][Full Text] [Related]
9. Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes.
Pruthi J; Mehra NK; Jain NK
J Drug Target; 2012 Aug; 20(7):593-604. PubMed ID: 22690657
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
12. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Agrawal P; Gupta U; Jain NK
Biomaterials; 2007 Aug; 28(22):3349-59. PubMed ID: 17459469
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
[TBL] [Abstract][Full Text] [Related]
14. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
Kaur A; Jain S; Tiwary AK
Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
[TBL] [Abstract][Full Text] [Related]
15. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.
Gupta Y; Jain A; Jain SK
J Pharm Pharmacol; 2007 Jul; 59(7):935-40. PubMed ID: 17637187
[TBL] [Abstract][Full Text] [Related]
18. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
19. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
